» Articles » PMID: 31220271

Allele Length of the DMPK CTG Repeat is a Predictor of Progressive Myotonic Dystrophy Type 1 Phenotypes

Overview
Journal Hum Mol Genet
Date 2019 Jun 21
PMID 31220271
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Myotonic dystrophy type 1 (DM1) is an autosomal dominant inherited disorder caused by expansion of a germline and somatically unstable CTG repeat in the DMPK gene. Previously, CTG repeat length at birth has been correlated to patient age at symptom onset. Attempts to correlate CTG repeat length with progressive DM1 phenotypes, such as muscle power, have proven difficult. To better correlate genotype with progressive phenotypes, we have measured CTG repeat tract length and screened for interrupting variant repeats in 192 study participants from a well-characterized Canadian cohort. We have assessed genotype-phenotype correlations with nine progressive measures of skeletal muscle power and respiratory function. We have built statistical models that include confounding factors such as sex, age, height and weight to further explain variation in muscle power. Our analysis reveals a strong correlation between DM1 genotype and respiratory function and skeletal muscle power, as part of a complex model that includes additional modulators such as sex, age, height, weight and the presence or absence of interrupting variant repeats. Distal skeletal muscle measurements, such as hand pinch and grip strength, show the strongest correlation with disease genotype. Detailed analysis of CTG repeat length, and incorporation of confounding factors, greatly improves the predictive ability of these models. They reveal a greater genetic influence on individual progressive phenotypes than on age at symptom onset and for clinical trials will help optimize stratification and explain patient variability. They will also help practitioners prioritize assessment of the muscular power measurements that correlate best with disease severity.

Citing Articles

Analysis of human urinary extracellular vesicles reveals disordered renal metabolism in myotonic dystrophy type 1.

Kumari P, Sullivan L, Li Z, Parker Conquest E, Cornforth E, Jayakumar R Nat Commun. 2025; 16(1):2158.

PMID: 40044661 PMC: 11882899. DOI: 10.1038/s41467-025-56479-5.


New Horizons in Myotonic Dystrophy Type 1: Cellular Senescence as a Therapeutic Target.

Legare C, Berglund J, Duchesne E, Dumont N Bioessays. 2024; 47(3):e202400216.

PMID: 39723693 PMC: 11848125. DOI: 10.1002/bies.202400216.


The Study of the Inheritance Mechanisms of Myotonic Dystrophy Type 1 (DM1) in Families from the Republic of North Ossetia-Alania.

Ionova S, Murtazina A, Marakhonov A, Shchagina O, Ryadninskaya N, Tebieva I Int J Mol Sci. 2024; 25(17).

PMID: 39273681 PMC: 11395446. DOI: 10.3390/ijms25179734.


Expression levels of core spliceosomal proteins modulate the MBNL-mediated spliceopathy in DM1.

Louis J, Frias J, Schroader J, Jones L, Davey E, Lennon C Hum Mol Genet. 2024; 33(21):1873-1886.

PMID: 39180495 PMC: 11540926. DOI: 10.1093/hmg/ddae125.


Myotonic dystrophy type 1 testing, 2024 revision: A technical standard of the American College of Medical Genetics and Genomics (ACMG).

Seifert B, Reddi H, Kang B, Bean L, Shealy A, Rose N Genet Med. 2024; 26(8):101145.

PMID: 38836869 PMC: 11298302. DOI: 10.1016/j.gim.2024.101145.


References
1.
Jinnai K, Mitani M, Futamura N, Kawamoto K, Funakawa I, Itoh K . Somatic instability of CTG repeats in the cerebellum of myotonic dystrophy type 1. Muscle Nerve. 2013; 48(1):105-8. DOI: 10.1002/mus.23717. View

2.
Jansen G, Willems P, Coerwinkel M, Nillesen W, Smeets H, Vits L . Gonosomal mosaicism in myotonic dystrophy patients: involvement of mitotic events in (CTG)n repeat variation and selection against extreme expansion in sperm. Am J Hum Genet. 1994; 54(4):575-85. PMC: 1918095. View

3.
Braida C, Stefanatos R, Adam B, Mahajan N, Smeets H, Niel F . Variant CCG and GGC repeats within the CTG expansion dramatically modify mutational dynamics and likely contribute toward unusual symptoms in some myotonic dystrophy type 1 patients. Hum Mol Genet. 2010; 19(8):1399-412. DOI: 10.1093/hmg/ddq015. View

4.
Logigian E, Moxley 4th R, Blood C, Barbieri C, Martens W, Wiegner A . Leukocyte CTG repeat length correlates with severity of myotonia in myotonic dystrophy type 1. Neurology. 2004; 62(7):1081-9. DOI: 10.1212/01.wnl.0000118206.49652.a3. View

5.
Ashizawa T, DUNNE C, Dubel J, Perryman M, Epstein H, Boerwinkle E . Anticipation in myotonic dystrophy. I. Statistical verification based on clinical and haplotype findings. Neurology. 1992; 42(10):1871-7. DOI: 10.1212/wnl.42.10.1871. View